首页> 美国政府科技报告 >Preclinical Validation of Anti-Nuclear Factor Kappa B Therapy Against Vestibular Schwannoma and Neurofibromatosis Type II.

【24h】

Preclinical Validation of Anti-Nuclear Factor Kappa B Therapy Against Vestibular Schwannoma and Neurofibromatosis Type II.

机译：临床前验证抗核因子Kappa治疗前庭神经鞘瘤和II型神经纤维瘤病。

获取原文

页面导航

著录项
引文网络
相似文献
相关主题

著录项

作者
Stankovic, K. M.;
展开▼
作者单位

展开▼
年度 2016
页码 1-42
总页数 42
原文格式 PDF
正文语种 eng
中图分类
关键词
Neoplasms; Brain; Genetic diseases; Hearing loss; Therapeutics; Drug therapy; Mice; Models; Aspirin; Ear;

机译：肿瘤;脑;遗传性疾病;听力丧失;治疗学;药物治疗;小鼠;模型;阿司匹林;耳;

相似文献

外文文献
中文文献
专利

1. Preclinical validation of anti-nuclear factor-kappa B therapy to inhibit human vestibular schwannoma growth [J] . Sonam Dilwali, Martijn C. Bri?t, Shyan-Yuan Kao, Molecular oncology. . 2015,第7期

机译：抗核因子κB抑制人前庭神经鞘瘤生长的临床前验证
2. Bevacizumab treatment for vestibular schwannomas in neurofibromatosis type two: report of two cases, including responses after prior gamma knife and vascular endothelial growth factor inhibition therapy. [J] . Eminowicz GK, Raman R, Conibear J, The Journal of laryngology and otology. . 2012,第1期

机译：贝伐单抗治疗第二型神经纤维瘤病的前庭神经鞘瘤：2例报告，包括先前使用伽玛刀后的反应和血管内皮生长因子抑制疗法。
3. Three-dimensional volumetrics for tracking vestibular schwannoma growth in neurofibromatosis type II. [J] . Harris GJ, Plotkin SR, Maccollin M Neurosurgery . 2008,第6Suppla期

机译：用于跟踪II型神经纤维瘤病中前庭神经鞘瘤生长的三维体积。
4. Long-Term Follow-up Results with Audiological Assessment After Fractionated Stereotactic Radiotherapy for Vestibular Schwannomas [C] . Yutaka Sawamura, Hiroki Shirato, Touru Sakamoto, Keio International Symposium for Life Sciences and Medicine . 2003

机译：随机学评估的长期随访结果分级后分级的立体定向放疗前庭施韦马斯
5. The Genetically Engineered Minipig as a Preclinical Disease Model for Neurofibromatosis Type 1 Syndrome [D] . Osum, Sara Hamman. 2020

机译：基因工程微型剂作为神经纤维瘤病1型综合征的临床前疾病模型
6. Preclinical validation of anti‐nuclear factor‐kappa B therapy to inhibit human vestibular schwannoma growth [O] . Sonam Dilwali, Martijn C. Briët, Shyan-Yuan Kao, 2015

机译：抗核因子κB抑制人前庭神经鞘瘤生长的临床前验证
7. The Effect of Bevacizumab on Vestibular Schwannoma Related to Neurofibromatosis Type 2 [O] . Simone Ardern-Holmes, Cassandra White, Sarita Bahure, 2021

机译：Bevacizumab对医院氏妇虫与神经纤维瘤病有关的影响
8. Preclinical Validation of Anti-Nuclear Factor Kappa B Therapy against Vestibular Schwannoma and Neurofibromatosis Type II. [R] . Stankovic, K. M. 2015

机译：临床前验证抗核因子Kappa治疗前庭神经鞘瘤和II型神经纤维瘤病。

Preclinical Validation of Anti-Nuclear Factor Kappa B Therapy Against Vestibular Schwannoma and Neurofibromatosis Type II.

著录项

引文网络

相似文献

相关主题

期刊订阅